Access cutting-edge t-cell leukemia treatment through this clinical trial at a research site in Memphis. Study-provided care at no cost to qualified participants.
Access t-cell leukemia specialists in Memphis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related t-cell leukemia treatment provided free
This is a clinical trial testing whether the addition of one of two chemotherapy agents, dasatinib or venetoclax, can improve outcomes for children and young adults with newly diagnosed T-cell acute lymphoblastic leukemia and lymphoma or mixed phenotype acute leukemia. Primary Objective * To evaluate if the end of induction MRD-negative rate is higher in patients with T-ALL treated with dasatinib compared to similar patients treated with 4-drug induction on AALL1231. * To evaluate if the end o
Sponsor: St. Jude Children's Research Hospital
Check if you qualify for this t-cell leukemia clinical trial in Memphis, TN
If you're searching for t-cell leukemia treatment options in Memphis, TN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Memphis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced t-cell leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.